Literature DB >> 17515677

[Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report].

Ugo Rotolo1, Francesco Scarlata, Salvatore Giordano, Calogera Tortorici, Luisa Bono, Mario Coglitore, Cesare Faraci, Laura Infurnari, Raffaella Rubino, Amelia Romano.   

Abstract

Strongyloidiasis is caused by a small intestinal nematode with a complex life cycle. In Italy the infection is endemic in rural areas of the Po Valley. The clinical syndrome of S. stercoralis encompasses a broad spectrum of symptoms and signs and, in the immunocompromised host, larvae can migrate to different organs and tissues. Also immune response seems to play a role in the pathogenesis of the disease. We report a case of strongyloidiasis complicated by Gram-negative sepsis and nephrotic syndrome in an immigrant from South America with a normal immune response. Whereas sepsis cleared up quickly, parasitic clearance was obtained only after treatment with ivermectin and nephrotic syndrome was still present three months after the end of treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515677

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  3 in total

1.  Comment about nephrotic syndrome in association with strongyloidiasis.

Authors:  Gioacchino Li Cavoli; Calogera Tortorici; Luisa Bono; Angelo Ferrantelli; Carlo Giammarresi; Ugo Rotolo
Journal:  Clin Exp Nephrol       Date:  2011-04-06       Impact factor: 2.801

2.  Imported strongyloidiasis: epidemiology, presentations, and treatment.

Authors:  Dora Buonfrate; Andrea Angheben; Federico Gobbi; Jose Muñoz; Ana Requena-Mendez; Eduardo Gotuzzo; Maria Alejandra Mena; Zeno Bisoffi
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 3.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.